TP53 and neoplasm: Our classifier extends recent gene expression-based models for TP53 functionality [20–23] by being able to generalize across both tumor and cancer cell lines (important for identifying drug sensitivity associations, see below), and moreover it can provide calibrated FDR estimates for TP53 functional status of each tumor or cell line.